Literature for peptidase M14.004: carboxypeptidase N

Summary Gene structure Alignment Tree Sequences Sequence features Distribution Structure Literature Substrates Pharma

(Topics flags: S Structure, A Assay, M Mutation, I Inhibitor, K Knockout, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

    2022
  1. Alfaro,E., Diaz-Garcia,E., Garcia-Tovar,S., Zamarron,E., Mangas,A., Galera,R., Nanwani-Nanwani,K., Perez-de-Diego,R., Lopez-Collazo,E., Garcia-Rio,F. and Cubillos-Zapata,C.
    Impaired Kallikrein-Kinin System in COVID-19 Patients' Severity
    Front Immunol (2022) 13, 909342-909342. PubMed  Europe PubMed DOI  PMC  EPMC
  2. 2021
  3. Zhou,Q., Zhao,L., Shao,Z., Declerck,P., Leung,L.L.K. and Morser,J.
    Both plasma basic carboxypeptidases, carboxypeptidase B2 and carboxypeptidase N, regulate vascular leakage activity in mice
    J Thromb Haemost (2021) 20, 238-244. PubMed  Europe PubMed DOI
  4. 2020
  5. Cui,R., Wang,C., Zhao,Q., Wang,Y. and Li,Y.
    Serum Carboxypeptidase N 1 Serves as a Potential Biomarker Complementing CA15-3 for Breast Cancer
    Anticancer Agents Med Chem (2020) PubMed  Europe PubMed DOI
  6. 2018
  7. Morser,J., Shao,Z., Nishimura,T., Zhou,Q., Zhao,L., Higgins,J. and Leung,L.L.K.
    Carboxypeptidase B2 and N play different roles in regulation of activated complements C3a and C5a in mice
    J Thromb Haemost (2018) 16, 991-1002. PubMed  Europe PubMed DOI  K
  8. 2017
  9. Wu,T.Y., Wang,Y.S., Song,Y.C., Chen,Z.Y., Chen,Y.T., Chiu,C.C. and Wu,C.Y.
    Fine-tune regulation of carboxypeptidase N1 controls vascular patterning during zebrafish development
    Sci Rep (2017) 7, 1852-1852. PubMed  Europe PubMed DOI  PMC  EPMC
  10. 2014
  11. Godahewa,G.I., Wickramaarachchi,W.D., Whang,I., Bathige,S.D., Lim,B.S., Choi,C.Y., De Zoysa,M., Noh,J.K. and Lee,J.
    Two carboxypeptidase counterparts from rock bream (Oplegnathus fasciatus): Molecular characterization, genomic arrangement and immune responses upon pathogenic stresses
    Vet Immunol Immunopathol (2014) 162, 180-191. PubMed  Europe PubMed DOI
  12. Hu,X., Wetsel,R.A., Ramos,T.N., Mueller-Ortiz,S.L., Schoeb,T.R. and Barnum,S.R.
    Carboxypeptidase N-deficient mice present with polymorphic disease phenotypes on induction of experimental autoimmune encephalomyelitis
    Immunobiology (2014) 219, 104-108. PubMed  Europe PubMed DOI  K
  13. 2012
  14. Darley,M.M., Ramos,T.N., Wetsel,R.A. and Barnum,S.R.
    Deletion of carboxypeptidase N delays onset of experimental cerebral malaria
    Parasite Immunol (2012) 34, 444-447. PubMed  Europe PubMed DOI  K
  15. Skidgel,R., Tan,F. and Erdos,E.G.
    Lysine carboxypeptidase/carboxypeptidase N
    [ISSN:978-0-12-407744-7] (2012) 3, 1334-1342. DOI
  16. 2009
  17. Du,X.Y., Zabel,B.A., Myles,T., Allen,S.J., Handel,T.M., Lee,P.P., Butcher,E.C. and Leung,L.L.
    Regulation of chemerin bioactivity by plasma carboxypeptidase N, carboxypeptidase B (activated thrombin-activable fibrinolysis inhibitor), and platelets
    J Biol Chem (2009) 284, 751-758. PubMed  Europe PubMed DOI  PMC  EPMC
  18. Mueller-Ortiz,S.L., Wang,D., Morales,J.E., Li,L., Chang,J.Y. and Wetsel,R.A.
    Targeted disruption of the gene encoding the murine small subunit of carboxypeptidase N (CPN1) causes susceptibility to C5a anaphylatoxin-mediated shock
    J Immunol (2009) 182, 6533-6539. PubMed  Europe PubMed DOI  K
  19. 2008
  20. Gils,A.
    Which carboxypeptidase determines the antifibrinolytic potential?
    J Thromb Haemost (2008) 6, 846-847. PubMed  Europe PubMed DOI
  21. Matthiessen,H.P., Willemse,J., Weber,A., Turecek,P.L., Deiteren,K., Hendriks,D., Ehrlich,H.J. and Schwarz,H.P.
    Ethanol dependence of alpha1-antitrypsin C-terminal Lys truncation mediated by basic carboxypeptidases
    Transfusion (2008) 48, 314-320. PubMed  Europe PubMed DOI
  22. Walker,J.B., Binette,T.M., Mackova,M., Lambkin,G.R., Mitchell,L. and Bajzar,L.
    Proteolytic cleavage of carboxypeptidase N markedly increases its antifibrinolytic activity
    J Thromb Haemost (2008) 6, 848-855. PubMed  Europe PubMed DOI
  23. Willemse,J.L., Polla,M., Olsson,T. and Hendriks,D.F.
    Comparative substrate specificity study of carboxypeptidase U (TAFIa) and carboxypeptidase N: development of highly selective CPU substrates as useful tools for assay development
    Clin Chim Acta (2008) 387, 158-160. PubMed  Europe PubMed DOI  A
  24. 2007
  25. Keil,C., Maskos,K., Than,M., Hoopes,J.T., Huber,R., Tan,F., Deddish,P.A., Erdos,E.G., Skidgel,R.A. and Bode,W.
    Crystal structure of the human carboxypeptidase N (kininase I) catalytic domain
    J Mol Biol (2007) 366, 504-516. PubMed  Europe PubMed DOI  S
  26. Skidgel,R.A. and Erdos,E.G.
    Structure and function of human plasma carboxypeptidase N, the anaphylatoxin inactivator
    Int Immunopharmacol (2007) 7, 1888-1899. PubMed  Europe PubMed DOI  PMC  EPMC  V
  27. 2005
  28. [YEAR:17-2-2005]Davis,D.A., Singer,K.E., Luz Sierra,M., Narazaki,M., Yang,F., Fales,H.M., Yarchoan,R. and Tosato,G.
    Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1alpha in the circulation
    Blood (17-2-2005) 105, 4561-4568. PubMed  Europe PubMed DOI  PMC  EPMC
  29. [YEAR:23-12-2005]Quagraine,M.O., Tan,F., Tamei,H., Erdos,E.G. and Skidgel,R.A.
    Plasmin alters the activity and quaternary structure of human plasma carboxypeptidase N
    Biochem J (23-12-2005) 388, 81-91. PubMed  Europe PubMed DOI  PMC  EPMC
  30. 2004
  31. Matthews,K.W., Mueller-Ortiz,S.L. and Wetsel,R.A.
    Carboxypeptidase N: a pleiotropic regulator of inflammation
    Mol Immunol (2004) 40, 785-793. PubMed  Europe PubMed DOI
  32. Skidgel,R.A. and Erdos,E.G.
    Lysine carboxypeptidase
    [ISSN:0-12-079610-4] (2004) 2, 837-840.  V
  33. 2003
  34. Cao,H. and Hegele,R.A.
    DNA polymorphism and mutations in CPN1, including the genomic basis of carboxypeptidase N deficiency
    J Hum Genet (2003) 48, 20-22. PubMed  Europe PubMed DOI  M
  35. 2000
  36. [YEAR:15-7-2000]Sato,T., Miwa,T., Akatsu,H., Matsukawa,N., Obata,K., Okada,N., Campbell,W. and Okada,H.
    Pro-carboxypeptidase R is an acute phase protein in the mouse, whereas carboxypeptidase N is not
    J Immunol (15-7-2000) 165, 1053-1058. PubMed  Europe PubMed
  37. 1997
  38. Plow,E.F., Allampallam,K. and Redlitz,A.
    The plasma carboxypeptidases and the regulation of the plasminogen system
    Trend.Cardiovasc.Med. (1997) 7, 71-75. PubMed  Europe PubMed DOI
  39. 1995
  40. Redlitz,A., Tan,A.K., Eaton,D.L. and Plow,E.F.
    Plasma carboxypeptidases as regulators of the plasminogen system
    J Clin Invest (1995) 96, 2534-2538. PubMed  Europe PubMed DOI  PMC  EPMC
  41. Skidgel,R.A.
    Human carboxypeptidase N: lysine carboxypeptidase
    Methods Enzymol (1995) 248, 653-663. PubMed  Europe PubMed DOI  V
  42. 1993
  43. Hendriks,D., Vingron,M., Vriend,G., Wang,W., Nalis,D. and Scharpe,S.
    On the specificity of carboxypeptidase N, a comparative study
    Biol Chem Hoppe Seyler (1993) 374, 843-849. PubMed  Europe PubMed
  44. 1991
  45. Drapeau,G., Chow,A. and Ward,P.E.
    Metabolism of bradykinin analogs by angiotensin I converting enzyme and carboxypeptidase N
    Peptides (1991) 12, 631-638. PubMed  Europe PubMed DOI
  46. 1990
  47. Tan,F., Weerasinghe,D.K., Skidgel,R.A., Tamei,H., Kaul,R.K., Roninson,I.B., Schilling,J.W. and Erdos,E.G.
    The deduced protein sequence of the human carboxypeptidase N high molecular weight subunit reveals the presence of leucine-rich tandem repeats
    J Biol Chem (1990) 265, 13-19. PubMed  Europe PubMed
  48. 1989
  49. Gebhard,W., Schube,M. and Eulitz,M.
    cDNA cloning and complete primary structure of the small, active subunit of human carboxypeptidase N (kininase 1)
    Eur J Biochem (1989) 178, 603-607. PubMed  Europe PubMed
  50. Skidgel,R.A., Weerasinghe,D.K. and Erdos,E.G.
    Structure of human carboxypeptidase N (kininase I)
    Adv Exp Med Biol (1989) 247A, 325-329. PubMed  Europe PubMed
  51. Tan,F., Jackman,H., Skidgel,R.A., Zsigmond,E.K. and Erdos,E.G.
    Protamine inhibits plasma carboxypeptidase N, the inactivator of anaphylatoxins and kinins
    Anesthesiology (1989) 70, 267-275. PubMed  Europe PubMed
  52. 1987
  53. Michelutti,L., Falter,H., Certossi,S., Marcotte,B. and Mazzuchin,A.
    Isolation and purification of creatine kinase conversion factor from human serum and its identification as carboxypeptidase N
    Clin Biochem (1987) 20, 21-29. PubMed  Europe PubMed
  54. 1986
  55. Mathews,K.P., Curd,J.G. and Hugli,T.E.
    Decreased synthesis of serum carboxypeptidase N (SCPN) in familial SCPN deficiency
    J Clin Immunol (1986) 6, 87-91. PubMed  Europe PubMed  K
  56. Skidgel,R.A., Kawahara,M.S. and Hugli,T.E.
    Functional significance of the subunits of carboxypeptidase N (kininase I)
    Adv Exp Med Biol (1986) 198 Pt A, 375-380. PubMed  Europe PubMed
  57. 1983
  58. Huey,R., Bloor,C.M., Kawahara,M.S. and Hugli,T.E.
    Potentiation of the anaphylatoxins in vivo using an inhibitor of serum carboxypeptidase N (SCPN). I. Lethality and pathologic effects on pulmonary tissue
    Am J Pathol (1983) 112, 48-60. PubMed  Europe PubMed  PMC  EPMC  I
  59. 1982
  60. Juillerat-Jeanneret,L., Roth,M. and Bargetzi,J.P.
    Some properties of porcine carboxypeptidase N
    Hoppe Seylers Z Physiol Chem (1982) 363, 51-58. PubMed  Europe PubMed
  61. Levin,Y., Skidgel,R.A. and Erdos,E.G.
    Isolation and characterization of the subunits of human plasma carboxypeptidase N (kininase i)
    Proc Natl Acad Sci U S A (1982) 79, 4618-4622. PubMed  Europe PubMed  PMC  EPMC
  62. Ranby,M.
    Studies on the kinetics of plasminogen activation by tissue plasminogen activator
    Biochim Biophys Acta (1982) 704, 461-469. PubMed  Europe PubMed
  63. 1981
  64. Plummer,T.H., Jr. and Erdos,E.G.
    Human plasma carboxypeptidase N
    Methods Enzymol (1981) 80, 442-449. PubMed  Europe PubMed DOI  V
  65. Plummer,T.H., Jr. and Ryan,T.J.
    A potent mercapto bi-product analogue inhibitor for human carboxypeptidase N
    Biochem Biophys Res Commun (1981) 98, 448-454. PubMed  Europe PubMed DOI  I
  66. 1980
  67. Mathews,K.P., Pan,P.M., Gardner,N.J. and Hugli,T.E.
    Familial carboxypeptidase N deficiency
    Ann Intern Med (1980) 93, 443-445. PubMed  Europe PubMed  K
  68. 1979
  69. [YEAR:15-10-1979]McKay,T.J., Phelan,A.W. and Plummer,T.H., Jr.
    Comparative studies on human carboxypeptidases B and N
    Arch Biochem Biophys (15-10-1979) 197, 487-492. PubMed  Europe PubMed
  70. [YEAR:17-4-1979]Ondetti,M.A., Condon,M.E., Reid,J., Sabo,E.F., Cheung,H.S. and Cushman,D.W.
    Design of potent and specific inhibitors of carboxypeptidases A and B
    Biochemistry (17-4-1979) 18, 1427-1430. PubMed  Europe PubMed  I
  71. 1978
  72. [YEAR:11-5-1978]Koheil,A. and Forstner,G.
    Isoelectric focusing of carboxypeptidase N
    Biochim Biophys Acta (11-5-1978) 524, 156-161. PubMed  Europe PubMed
  73. [YEAR:10-6-1978]Plummer,T.H., Jr. and Hurwitz,M.Y.
    Human plasma carboxypeptidase N. Isolation and characterization
    J Biol Chem (10-6-1978) 253, 3907-3912. PubMed  Europe PubMed
  74. 1975
  75. Oshima,G., Kato,J. and Erdos,E.G.
    Plasma carboxypeptidase N, subunits and characteristics
    Arch Biochem Biophys (1975) 170, 132-138. PubMed  Europe PubMed
  76. 1974
  77. Oshima,G., Kato,J. and Erdos,E.G.
    Subunits of human plasma carboxypeptidase N (kininase I; anaphylatoxin inactivator)
    Biochim Biophys Acta (1974) 365, 344-348.
  78. 1970
  79. Bokisch,V.A. and Muller-Eberhard,H.J.
    Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase
    J Clin Invest (1970) 49, 2427-2436. PubMed  Europe PubMed DOI  PMC  EPMC
  80. 1967
  81. [YEAR:7-7-1967]Erdos,E.G., Yang,H.Y., Tague,L.L. and Manning,N.
    Carboxypeptidase in blood and other fluids. 3. The esterase activity of the enzyme
    Biochem Pharmacol (7-7-1967) 16, 1287-1297. PubMed  Europe PubMed
  82. 1965
  83. Erdos,E.G., Wohler,I.M., Levine,I.M. and Westerman,M.P.
    Carboxypeptidase in blood and other fluids. Values in human blood in normal and pathological conditions
    Clin Chim Acta (1965) 11, 39-43. PubMed  Europe PubMed
  84. 1962
  85. Erdos,E.G. and Sloane,E.M.
    An enzyme in human blood plasma that inactivates bradykinin and kallidins
    Biochem Pharmacol (1962) 11, 585-592. PubMed  Europe PubMed